Francesco Bertolini
Francesco Bertolini
Director, Division of Laboratory Hematology-Oncology, European Institute of Oncology
Verified email at
Cited by
Cited by
Chimerism of the transplanted heart
F Quaini, K Urbanek, AP Beltrami, N Finato, CA Beltrami, B Nadal-Ginard, ...
New England Journal of Medicine 346 (1), 5-15, 2002
The multifaceted circulating endothelial cell in cancer: towards marker and target identification
F Bertolini, Y Shaked, P Mancuso, RS Kerbel
Nature Reviews Cancer 6 (11), 835-845, 2006
Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells
F Bertolini, S Paul, P Mancuso, S Monestiroli, A Gobbi, Y Shaked, ...
Cancer research 63 (15), 4342-4346, 2003
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
P Mancuso, A Burlini, G Pruneri, A Goldhirsch, G Martinelli, F Bertolini
Blood 97 (11), 3658-3661, 2001
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings
F Belli, A Testori, L Rivoltini, M Maio, G Andreola, MR Sertoli, G Gallino, ...
Journal of Clinical Oncology 20 (20), 4169-4180, 2002
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents
Y Shaked, E Henke, JML Roodhart, P Mancuso, MHG Langenberg, ...
Cancer cell 14 (3), 263-273, 2008
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: implications for cellular surrogate marker analysis of antiangiogenesis
Y Shaked, F Bertolini, S Man, MS Rogers, D Cervi, T Foutz, K Rawn, ...
Cancer cell 7 (1), 101-111, 2005
Circulating endothelial cells
AD Blann, A Woywodt, F Bertolini, TM Bull, JP Buyon, RM Clancy, ...
Thrombosis and haemostasis 93 (02), 228-235, 2005
Angiogenesis in myelodysplastic syndromes
G Pruneri, F Bertolini, D Soligo, N Carboni, A Cortelezzi, PF Ferrucci, ...
British journal of cancer 81 (8), 1398-1401, 1999
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer
S Dellapasqua, F Bertolini, V Bagnardi, E Campagnoli, E Scarano, ...
Journal of Clinical Oncology 26 (30), 4899-4905, 2008
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin’s lymphoma
F Bertolini, C Dell’Agnola, P Mancuso, C Rabascio, A Burlini, ...
Cancer Research 62 (11), 3106-3112, 2002
Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity
Y Shaked, U Emmenegger, S Man, D Cervi, F Bertolini, Y Ben-David, ...
Blood 106 (9), 3058-3061, 2005
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy
P Mancuso, M Colleoni, A Calleri, L Orlando, P Maisonneuve, G Pruneri, ...
Blood 108 (2), 452-459, 2006
Antagonism of peripheral inflammation reduces the severity of status epilepticus
N Marchi, Q Fan, C Ghosh, V Fazio, F Bertolini, G Betto, A Batra, E Carlton, ...
Neurobiology of disease 33 (2), 171-181, 2009
Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study
C Mucciarini, G Rossi, F Bertolini, R Valli, C Cirilli, I Rashid, L Marcheselli, ...
BMC cancer 7 (1), 230, 2007
Locoregional recurrence risk after lipofilling in breast cancer patients
JY Petit, E Botteri, V Lohsiriwat, M Rietjens, F De Lorenzi, C Garusi, ...
Annals of Oncology 23 (3), 582-588, 2012
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
C Bengala, F Bertolini, N Malavasi, C Boni, E Aitini, C Dealis, S Zironi, ...
British journal of cancer 102 (1), 68-72, 2010
Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma
S Monestiroli, P Mancuso, A Burlini, G Pruneri, C Dell’Agnola, A Gobbi, ...
Cancer Research 61 (11), 4341-4344, 2001
In vitro assessment of the quality of stored platelet concentrates
S Murphy, P Rebulla, F Bertolini, S Holme, G Moroff, E Snyder, ...
Transfusion medicine reviews 8 (1), 29-36, 1994
Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients
F Bertolini, M Battaglia, P Pedrazzoli, G Antonio Da Prada, A Lanza, ...
Blood, The Journal of the American Society of Hematology 89 (8), 2679-2688, 1997
The system can't perform the operation now. Try again later.
Articles 1–20